Niagen Bioscience Inc. Live Share Price Today, Share Analysis and Chart

Name: Niagen Bioscience Inc.: Is Infosys Ltd. worth buying?
Item: Niagen Bioscience Inc.
Rating: 3.092763875
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven t...

11.30 -0.49 (-4.16%)

346.64% Gain from 52W Low

925.5K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

High Financial Strength

72.2 / 100

Mid Valuation

34.2 / 100

Technically Moderately Bullish

68.8 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

1Yr Price target upside is 32%

4 analysts

Niagen Bioscience Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Niagen Bioscience Inc. Live Share Price Today, Share Analysis and Chart

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven t...

346.64% Gain from 52W Low

SWOT Analysis

Niagen Bioscience Inc. Live Price Chart